基于预测的睡前干预减少成人1型糖尿病夜间低血糖的评估:DailyDose睡前智能零食交叉研究
研究开发了DailyDose智能零食(DDSS)应用,基于CGM和体力活动记录及证据神经网络预测低血糖概率与时机,提供个性化睡前零食建议。随机交叉试验纳入20例成人1型糖尿病,比较DDSS联合CGM增强的多日多次注射(MDI)与单用CGM增强MDI各4周,发现夜间低血糖事件(<70 mg/dL持续≥10 min)比例无显著差异(对照组26.0% vs DDSS组23.6%,OR 0.83,P=0.207),但事后分析显示DDSS组<54 mg/dL持续≥10 min的低血糖事件比例显著降低3.5%(11.9% vs 8.3%,OR 0.64,P=0.040)。
要点
- DDSS应用未显著减少夜间<70 mg/dL持续≥10 min的低血糖事件比例(OR 0.83,P=0.207)。
- 事后分析显示DDSS组夜间<54 mg/dL持续≥10 min的低血糖事件比例降低3.5%(OR 0.64,P=0.040)。
- DDSS未对其他血糖指标造成不良影响。
核心结论
- DDSS未显著减少夜间<70 mg/dL持续≥10 min的低血糖事件比例,但减少了夜间<54 mg/dL的低血糖且未损害其他血糖指标。
研究设计与样本
- 随机交叉试验,比较DDSS联合CGM增强的MDI与单用CGM增强的MDI各4周,在自由生活条件下评估可行性及减少夜间低血糖的效果。
- 20名成人1型糖尿病患者完成研究,平均±SD年龄39±15岁,女性10名,HbA1c 7.1%±1.0%(54±11 mmol/mol)。
主要发现
- 夜间<70 mg/dL持续≥10 min的低血糖事件比例:对照组26.0%±14.1% vs DDSS组23.6%±15.6%,OR 0.83,P=0.207,无显著差异。
- 夜间CGM指标两组间无差异。
- 事后分析:夜间<54 mg/dL持续≥10 min的低血糖事件比例DDSS组较对照组降低3.5%(11.9%±12.9% vs 8.3%±8.8%,OR 0.64,P=0.040)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Nocturnal hypoglycemia is challenging for individuals with type 1 diabetes, particularly those who are physically active or using multiple daily injections (MDIs). We hypothesized that adding bedtime decision support to usual care with continuous glucose monitoring (CGM)-augmented MDI therapy could reduce nocturnal hypoglycemia. RESEARCH DESIGN AND METHODS: We developed the DailyDose Smart Snack (DDSS) app, which features CGM and physical activity logging and delivers personalized bedtime snack recommendations to help prevent nocturnal hypoglycemia. Recommendations are based on the probability and timing of low-glucose events forecasted by an evidential neural network. We conducted a randomized crossover trial comparing DDSS with CGM-augmented MDI for 4 weeks each under free-living conditions to evaluate the feasibility and effect of DDSS in reducing nocturnal hypoglycemia. RESULTS: Twenty participants completed the study (mean ± SD age 39 ± 15 years; 10 women; HbA1c 7.1% ± 1.0% [54 ± 11 mmol/mol]). There was no difference between arms in the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min (control 26.0% ± 14.1% vs. DDSS 23.6% ± 15.6%; odds ratio [OR] 0.83; P = 0.207) or in overnight CGM metrics. A post hoc analysis showed that the proportion of nights with low-glucose events <54 mg/dL lasting ≥10 min was significantly reduced in the DDSS arm by 3.5% (11.9% ± 12.9% vs. 8.3% ± 8.8%; OR 0.64; P = 0.040). CONCLUSIONS: DDSS did not significantly reduce the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min but reduced nocturnal low glucose <54 mg/dL without compromising other glycemic metrics.
引用
- Mosquera-Lopez C, Roquemen-Echeverri V, Jacobs PG, et al. Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study. Diabetes Care. 2025. PMID: 40705054. doi:10.2337/dc25-0407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。